Navigation Links
OncoSec Medical to Present at the 25th Annual Roth Conference
Date:3/14/2013

SAN DIEGO, March 14, 2013 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that Punit Dhillon , President and CEO, will present at the 25th Annual Roth Conference at the Ritz-Carlton, Laguna Niguel in Dana Point, California, on Tuesday, March 19th at 8:00AM Pacific Time.

(Logo: http://photos.prnewswire.com/prnh/20120905/LA68078LOGO)

Mr. Dhillon will provide an overview of the Company and its milestones during the presentation, and will be conducting one-on-one meetings with investors who are registered to attend the conference. 

The presentation will be webcast live. To access the webcast, please visit  http://wsw.com/webcast/roth27/oncs/. The webcast will be archived for 90 days.

About the Annual Roth Conference

The 25th Annual Roth Conference is designed to provide investors with a unique opportunity to gain insight into emerging growth companies across a variety of sectors, including Business Services, Consumer, Cleantech, Industrials & Resources, Healthcare, Metals & Mining and Technology & Media.

The event is one of the largest of its kind in the U.S. It will feature presentations from hundreds of growth companies, expert panels and thousands of management one-on-one/small group meetings. To find out more, visit www.roth.com.

About OncoSec Medical Inc.

OncoSec Medical Inc. is a biopharmaceutical company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers. ImmunoPulse and NeoPulse th
'/>"/>

SOURCE OncoSec Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. OncoSec Medical Issues Letter to Shareholders
3. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
4. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
5. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
6. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
7. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
8. OncoSec Granted New Patent from China
9. OncoSec to Present at Upcoming Healthcare and Investor Conferences
10. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
11. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)...  According to their CEO, Rob Bohacs ... is going through a complete transformation with highly ... the current clinical trial management process isn,t configured ... trials, which will ultimately drive the prescription cancer ... has been recognized by the National Cancer Institute as ...
(Date:9/30/2014)... 30, 2014  Alimera Sciences, Inc. (NASDAQ: ... the research, development and commercialization of prescription ophthalmic pharmaceuticals, ... advance from Hercules Technology Growth Capital, Inc. (NYSE: ... and final advance under the Loan and Security Agreement ... , Alimera Sciences Limited, entered into with Hercules ...
(Date:9/30/2014)... -- A study using a relatively new imaging tool, ... the composition of carotid artery disease and has the ... disease, a leading cause of stroke. ... 2010 and May 2012, was featured in the June ... College of Cardiology (JACC) Cardiovascular Interventions. Interventional cardiologist ...
Breaking Medicine Technology:Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital 2New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2
... 21, 2012 InterMune, Inc. (NASDAQ: ITMN ... agreement with Vidara Therapeutics International Limited (Vidara) to sell ... transaction valued at $55 million plus a two-year royalty ... group of companies with operations in Ireland and the ...
... 2012  Consumers Union, the policy and advocacy arm of Consumer Reports, ... patients at risk in a full-page print ad in ... vote on a bill this week to reauthorize the statute governing ... that the FDA does not have the power under current law ...
Cached Medicine Technology:InterMune to Divest Actimmune® (Interferon Gamma-1b) 2InterMune to Divest Actimmune® (Interferon Gamma-1b) 3Dangerous Medical Device Loophole Puts Patients At Risk 2Dangerous Medical Device Loophole Puts Patients At Risk 3
(Date:10/1/2014)... co-funded by the Engineering and Physical Sciences Research ... the UK,s vital industrial control systems which run, ... grid, and the rail network. , The ... hackers or malware infiltrating the systems behind our ... in Trustworthy Industrial Control Systems (RITICS), based at ...
(Date:10/1/2014)... Marriagelifeinsurance.com has released a new ... retired couples. , Senior citizens can purchase a ... their loved ones. A joint policy is cheaper, but ... away. , Life insurance can be used to ... even be purchased online, as the application process is ...
(Date:10/1/2014)... October 01, 2014 Phoseon Technology, the ... continues to expand the business worldwide. This rapid growth ... additional capacity for manufacturing efforts. The company has experienced ... five years and expects this growth to continue in ... technology gains worldwide adoption. , “We are very ...
(Date:10/1/2014)... California (PRWEB) October 01, 2014 Beverly ... Dr. Kathleen Mojas is celebrating 20 years of private ... assisted hundreds of people to achieve greater joy and ... important list of warning signs and suggestions for anyone ... Dr. Mojas explains: “Believe it or not, it’s ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Anti Aging ... and skin rejuvenating destination of choice, is announcing a ... October through to December. , “We’re doing this because ... possible to our top skin clinic in Toronto,” says ... do so much at Anti Aging Clinic, including laser ...
Breaking Medicine News(10 mins):Health News:£2.5 million to recognize and reduce cyber-attack threats to critical infrastructure 2Health News:Elderly Life Insurance - Find Life Insurance for Retired Couples! 2Health News:Phoseon Technology Continues to Drive Growth Worldwide 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 3Health News:Anti Aging Clinic, the GTA’s Premier Provider of Anti Aging Treatments, Announces Deal on Units of Botox 2
... Calif., Jan. 15 Abaxis, Inc.,(Nasdaq: ABAX ... systems, announced today that Clint Severson, CEO and,President, ... Company Emerging,Growth Conference on Wednesday, January 23, 2008 ... at The Ritz-Carlton, Palm Beach Florida., About ...
... incidence of liver cancer continues to grow-- fueled in large ... too does the need for tests to help diagnose the ... in the January 15 issue of Clinical Cancer Research demonstrates ... more accurate than traditional biomarkers in distinguishing liver cancer patients ...
... 14 Access,Pharmaceuticals, Inc. (OTC Bulletin Board: ... pharmaceutical company focused on bringing,proprietary medicines to ... of a,definitive licensing agreement under which RHEI, ... penetrating large volume hospitals, will,market Access,s proprietary ...
... MINRAD,International, Inc. (Amex: BUF ) today announced the ... Jr. as the new Chief,Financial Officer and Executive Vice ... from Hardinge, Inc., where he has been the,Chief Financial ... he served as the Chief Financial Officer and Treasurer ...
... American Physical Therapy Association Sponsors National Toll-Free,Hotline Addressing Ways ... ALEXANDRIA, Va., Jan. 14 Falls are,prevalent, dangerous, and ... nearly one in two seniors over age 80, will ... consequences.* As our nation,s population,ages, the rate of falls ...
... 14 The Lake Forest Hospital,Foundation board of directors ... create a new health care system for northeastern Illinois,and ... by a,combination of both hospital boards and would bring ... consumer ranked hospitals in,Lake County.*, As part of ...
Cached Medicine News:Health News:Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 2Health News:Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer 3Health News:Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries 2Health News:Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries 3Health News:MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP 2Health News:MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP 3Health News:Physical Therapist Intervention for Balance Impairments May Help Reduce Risk of Falling 2Health News:Physical Therapist Intervention for Balance Impairments May Help Reduce Risk of Falling 3Health News:Physical Therapist Intervention for Balance Impairments May Help Reduce Risk of Falling 4Health News:Lake Forest Hospital Proposes a New Health Care System in Lake County 2
... The Vasotrax is an ... pressure and heart rate non-invasively, ... fact, significantly more accurate than ... On a full battery charge, ...
... are heterodimeric proteins that suppress the secretion ... pituitary. Inhibin consists of two distinct chains, ... Inhibin A consists of the alpha-subunit and ... and betaB-subunit. Only the dimeric forms of ...
... (IGF-II) is a 7.5 kDa peptide which is ... to have mitogenic and metabolic actions involved in ... by binding to target cell receptors. IGF-II binds ... receptor, a monomeric protein which also serves as ...
... Pregnancy-associated plasma protein A (PAPP-A) is ... is produced in high concentrations by ... into the maternal circulation in increasing ... PAPP-A is not specific to pregnancy ...
Medicine Products: